Spontaneous Hemopericardium and Tamponade After Initiation of Anticoagulation in a Patient With Atrial Fibrillation and End Stage Renal Disease; Should We Anticoagulate Patients on Hemodialysis?

Vazquez-Fuster, Juan; Escabí-Mendoza, José

doi:10.1016/s0735-1097(21)04362-x

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although anticoagulation is beneficial in patients with atrial fibrillation (AF) without end-stage renal disease (ESRD), data regarding both the efficacy and safety of most anticoagulants in patients with AF and ESRD is sparse. In addition, these are largely observational, and it is important to remember that patients with renal impairment have been excluded from the major clinical trials regarding this matter [1]. In this case, we are presenting a patient with ESRD with a new-onset AF who inadvertently developed hemorrhagic pericarditis/hemopericardium in the setting of dialysis-associated pericarditis.…”

Section: Introductionmentioning

confidence: 99%

Cardiac Tamponade Risk Associated With Anticoagulation for Atrial Fibrillation in Dialysis-Associated Pericarditis: A Case Report

Abu-Abaa¹,

Hassan²,

Mousa³

et al. 2023

Cureus

View full text Add to dashboard Cite

Heparin is a preferred initial anticoagulant in patients with new-onset atrial fibrillation (AF). Despite continuous debate about the risk, there has been a concern about heparin-induced hemorrhagic pericarditis and cardiac tamponade. We present a case of a new onset atrial fibrillation (AF) in a patient with renal impairment and evidence of pericardial effusion complicated by hemopericardium development after starting anticoagulation. Although the risk of hemorrhagic conversion of uremic pericarditis induced by heparin in ESRD patients with new onset AF was suggested in the literature, this case raises the possibility of a similar complication in dialysis-associated pericarditis. Therefore, we aim to heighten alertness regarding this potential complication of a commonly used medication in clinical practice. We also aim to review the current anticoagulation recommendations in this setting.

show abstract

Section: Introductionmentioning

confidence: 99%